We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Using Proteomics to Develop Advanced Protein Biomarker Tests that Address Key Unmet Clinical Needs in Psoriatic Disease

Speaking in June 2021 at the online symposium, Advances in Proteomics & Metabolomics, Prof. Stephen Pennington, Professor of Proteomics at University College Dublin presented his keynote talk on developing advanced protein
biomarker tests for psoriatic disease.

Abstract: In this presentation the challenges of developing new protein biomarker tests and delivering them to use for patient benefit will be described and possible solutions introduced. Emphasis will be placed on the analytical validation of new multiplexed protein biomarker assays and their use in multi-centre evaluation and validation studies to support the development of new tests to improve patient outcomes in psoriatic disease. Patient engagement and use of patient-centric sampling devices for effective test delivery will be described.